Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-18

Clinical Trial Update: Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy

View source ↗

Summary

An ongoing clinical study at University of Erlangen-Nürnberg Medical School is examining immune biomarkers in prostate cancer patients treated with brachytherap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Prostate Cancer (Diagnosis), Prostate Cancer Patients Who Have Brachytherapy Seed Implant | Status: RECRUITING